ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Preparing for the rapid research response to the possible vertical transmission of Oropouche virus. [Carta]: lessons from a decade of congenital Zika research (2024)
Brickley, Elizabeth B; Miranda-Filho, Demócrito de Barros; Ximenes, Ricardo Arraes de Alencar; Albuquerque, Maria de Fátima P M de; Albuquerque, Maria do Socorro Veloso de; Almeida, Bethânia de Araujo; Araújo, Thalia Velho Barreto de; Barreto, Mauricio Lima; Duarte, Geraldo ; Mussi-Pinhata, Marisa Márcia
Fonte: The Lancet Infectious Diseases. Unidade: FMRP
Assuntos: ARBOVÍRUS, ZIKA VÍRUS, VIROLOGIA, SAÚDE MATERNO-INFANTIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRICKLEY, Elizabeth B et al. Preparing for the rapid research response to the possible vertical transmission of Oropouche virus. [Carta]: lessons from a decade of congenital Zika research. The Lancet Infectious Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S1473-3099(24)00618-2. Acesso em: 03 nov. 2025. , 2024
APA
Brickley, E. B., Miranda-Filho, D. de B., Ximenes, R. A. de A., Albuquerque, M. de F. P. M. de, Albuquerque, M. do S. V. de, Almeida, B. de A., et al. (2024). Preparing for the rapid research response to the possible vertical transmission of Oropouche virus. [Carta]: lessons from a decade of congenital Zika research. The Lancet Infectious Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/S1473-3099(24)00618-2
NLM
Brickley EB, Miranda-Filho D de B, Ximenes RA de A, Albuquerque M de FPM de, Albuquerque M do SV de, Almeida B de A, Araújo TVB de, Barreto ML, Duarte G, Mussi-Pinhata MM. Preparing for the rapid research response to the possible vertical transmission of Oropouche virus. [Carta]: lessons from a decade of congenital Zika research [Internet]. The Lancet Infectious Diseases. 2024 ; 24( 12): e725-e726.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(24)00618-2
Vancouver
Brickley EB, Miranda-Filho D de B, Ximenes RA de A, Albuquerque M de FPM de, Albuquerque M do SV de, Almeida B de A, Araújo TVB de, Barreto ML, Duarte G, Mussi-Pinhata MM. Preparing for the rapid research response to the possible vertical transmission of Oropouche virus. [Carta]: lessons from a decade of congenital Zika research [Internet]. The Lancet Infectious Diseases. 2024 ; 24( 12): e725-e726.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(24)00618-2
Artigo de periodico-carta/editorial
Dengue fever. [Carta]: working towards global control considering biological, social, and planetary determinants (2023)
Bellissimo-Rodrigues, Fernando; Dal-Fabbro, Amaury Lelis
Fonte: The Lancet Infectious Diseases. Unidade: FMRP
Assuntos: DENGUE, EPIDEMIOLOGIA, SURTOS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BELLISSIMO-RODRIGUES, Fernando e DAL-FABBRO, Amaury Lelis. Dengue fever. [Carta]: working towards global control considering biological, social, and planetary determinants. The Lancet Infectious Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S1473-3099(23)00632-1. Acesso em: 03 nov. 2025. , 2023
APA
Bellissimo-Rodrigues, F., & Dal-Fabbro, A. L. (2023). Dengue fever. [Carta]: working towards global control considering biological, social, and planetary determinants. The Lancet Infectious Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/S1473-3099(23)00632-1
NLM
Bellissimo-Rodrigues F, Dal-Fabbro AL. Dengue fever. [Carta]: working towards global control considering biological, social, and planetary determinants [Internet]. The Lancet Infectious Diseases. 2023 ; 23( 12):[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(23)00632-1
Vancouver
Bellissimo-Rodrigues F, Dal-Fabbro AL. Dengue fever. [Carta]: working towards global control considering biological, social, and planetary determinants [Internet]. The Lancet Infectious Diseases. 2023 ; 23( 12):[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(23)00632-1
Artigo de periodico-carta/editorial
Protection against COVID-19: beyond antibodies (2022)
Lacerda, Marcus Vinícius Guimarães ; Bargieri, Daniel Youssef
Fonte: The Lancet Infectious Diseases. Unidade: ICB
Assuntos: PARASITOLOGIA, COVID-19, VÍRUS DE RNA, RNA VIRAL, INFECÇÕES POR CORONAVIRUS, VACINAS VIRAIS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LACERDA, Marcus Vinícius Guimarães e BARGIERI, Daniel Youssef. Protection against COVID-19: beyond antibodies. The Lancet Infectious Diseases. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S1473-3099(21)00561-2. Acesso em: 03 nov. 2025. , 2022
APA
Lacerda, M. V. G., & Bargieri, D. Y. (2022). Protection against COVID-19: beyond antibodies. The Lancet Infectious Diseases. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/S1473-3099(21)00561-2
NLM
Lacerda MVG, Bargieri DY. Protection against COVID-19: beyond antibodies [Internet]. The Lancet Infectious Diseases. 2022 ; 22( 1): 4-5.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(21)00561-2
Vancouver
Lacerda MVG, Bargieri DY. Protection against COVID-19: beyond antibodies [Internet]. The Lancet Infectious Diseases. 2022 ; 22( 1): 4-5.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(21)00561-2
Artigo de periodico
Are leprosy case numbers reliable? (2018)
Salgado, Claudio Guedes ; Barreto, Josafá Gonçalves; Silva, Moisés Batista da; Goulart, Isabela Maria Bernardes; Barreto, Jaison Antônio; Medeiros Junior, Nesio Fernandes de; Nery, José Augusto; Frade, Marco Andrey Cipriani ; Spencer, John Stewart
Fonte: The Lancet Infectious Diseases. Unidade: FMRP
Assuntos: MÉTODOS EPIDEMIOLÓGICOS, HANSENÍASE, PREVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALGADO, Claudio Guedes et al. Are leprosy case numbers reliable?. The Lancet Infectious Diseases, v. 18, n. 2, p. 135-137, 2018Tradução . . Disponível em: https://doi.org/10.1016/s1473-3099(18)30012-4. Acesso em: 03 nov. 2025.
APA
Salgado, C. G., Barreto, J. G., Silva, M. B. da, Goulart, I. M. B., Barreto, J. A., Medeiros Junior, N. F. de, et al. (2018). Are leprosy case numbers reliable? The Lancet Infectious Diseases, 18( 2), 135-137. doi:10.1016/s1473-3099(18)30012-4
NLM
Salgado CG, Barreto JG, Silva MB da, Goulart IMB, Barreto JA, Medeiros Junior NF de, Nery JA, Frade MAC, Spencer JS. Are leprosy case numbers reliable? [Internet]. The Lancet Infectious Diseases. 2018 ; 18( 2): 135-137.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/s1473-3099(18)30012-4
Vancouver
Salgado CG, Barreto JG, Silva MB da, Goulart IMB, Barreto JA, Medeiros Junior NF de, Nery JA, Frade MAC, Spencer JS. Are leprosy case numbers reliable? [Internet]. The Lancet Infectious Diseases. 2018 ; 18( 2): 135-137.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/s1473-3099(18)30012-4
Artigo de periodico-carta/editorial
What do we actually know about leprosy worldwide ? [Carta] (2016)
Salgado, Claudio Guedes; Barreto, Josafá Gonçalves; Silva, Moisés Batista da; Frade, Marco Andrey Cipriani; Spencer, John Stewart
Fonte: The Lancet Infectious Diseases. Unidade: FMRP
Assunto: HANSENÍASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALGADO, Claudio Guedes et al. What do we actually know about leprosy worldwide ? [Carta]. The Lancet Infectious Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S1473-3099(16)30090-1. Acesso em: 03 nov. 2025. , 2016
APA
Salgado, C. G., Barreto, J. G., Silva, M. B. da, Frade, M. A. C., & Spencer, J. S. (2016). What do we actually know about leprosy worldwide ? [Carta]. The Lancet Infectious Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/S1473-3099(16)30090-1
NLM
Salgado CG, Barreto JG, Silva MB da, Frade MAC, Spencer JS. What do we actually know about leprosy worldwide ? [Carta] [Internet]. The Lancet Infectious Diseases. 2016 ; 16( 7): 778.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(16)30090-1
Vancouver
Salgado CG, Barreto JG, Silva MB da, Frade MAC, Spencer JS. What do we actually know about leprosy worldwide ? [Carta] [Internet]. The Lancet Infectious Diseases. 2016 ; 16( 7): 778.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(16)30090-1
Artigo de periodico-carta/editorial
Dengue outlook for the World Cup in Brazil. [Letter] (2014)
Massad, Eduardo ; Burattini, Marcelo Nascimento; Ximenes, Raphael; Amaku, Marcos; Wilder-Smith, Annelies
Fonte: The Lancet Infectious Diseases. Unidades: FM, FMVZ
Assuntos: DENGUE (PREVISÃO), EPIDEMIOLOGIA, EVENTOS ESPORTIVOS, SAÚDE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASSAD, Eduardo et al. Dengue outlook for the World Cup in Brazil. [Letter]. The Lancet Infectious Diseases. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S1473-3099(14)70807-2. Acesso em: 03 nov. 2025. , 2014
APA
Massad, E., Burattini, M. N., Ximenes, R., Amaku, M., & Wilder-Smith, A. (2014). Dengue outlook for the World Cup in Brazil. [Letter]. The Lancet Infectious Diseases. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S1473-3099(14)70807-2
NLM
Massad E, Burattini MN, Ximenes R, Amaku M, Wilder-Smith A. Dengue outlook for the World Cup in Brazil. [Letter] [Internet]. The Lancet Infectious Diseases. 2014 ; 14( 7): 552\2013553.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(14)70807-2
Vancouver
Massad E, Burattini MN, Ximenes R, Amaku M, Wilder-Smith A. Dengue outlook for the World Cup in Brazil. [Letter] [Internet]. The Lancet Infectious Diseases. 2014 ; 14( 7): 552\2013553.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(14)70807-2
Artigo de periodico
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study (2014)
Grant, Robert M.; Anderson, Peter L.; McMahan, Vanessa; Liu, Albert; Amico, K. Rivet; Mehrotra, Megha; Hosek, Sybil; Mosquera, Carlos; Casapia, Martin; Montoyaj, Orlando; Buchbinder, Susan; Veloso, Valdilea G.; Mayer, Kenneth; Chariyalertsak, Suwat; Bekker, Linda-Gail; Kallas, Esper G.; Schechter, Mauro; Guanira, Juan; Bushman, Lane; Burns, David N.; Rooney, James F.; Glidden, David V.
Fonte: The Lancet Infectious Diseases. Unidade: FM
Assuntos: SEXO, INFECÇÕES POR HIV (INCIDÊNCIA), HOMENS, TRANSEXUALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRANT, Robert M. et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. The Lancet Infectious Diseases, v. 14, n. 9, p. 820-829, 2014Tradução . . Disponível em: http://www.sciencedirect.com/science/article/pii/S1473309914708473#. Acesso em: 03 nov. 2025.
APA
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., et al. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. The Lancet Infectious Diseases, 14( 9), 820-829. doi:10.1016/s1473-3099(14)70847-3
NLM
Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, Hosek S, Mosquera C, Casapia M, Montoyaj O, Buchbinder S, Veloso VG, Mayer K, Chariyalertsak S, Bekker L-G, Kallas EG, Schechter M, Guanira J, Bushman L, Burns DN, Rooney JF, Glidden DV. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study [Internet]. The Lancet Infectious Diseases. 2014 ; 14( 9): 820-829.[citado 2025 nov. 03 ] Available from: http://www.sciencedirect.com/science/article/pii/S1473309914708473#
Vancouver
Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, Hosek S, Mosquera C, Casapia M, Montoyaj O, Buchbinder S, Veloso VG, Mayer K, Chariyalertsak S, Bekker L-G, Kallas EG, Schechter M, Guanira J, Bushman L, Burns DN, Rooney JF, Glidden DV. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study [Internet]. The Lancet Infectious Diseases. 2014 ; 14( 9): 820-829.[citado 2025 nov. 03 ] Available from: http://www.sciencedirect.com/science/article/pii/S1473309914708473#
Artigo de periodico
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial (2011)
Babiker, A.; Castro nee Green, H.; Compagnucci, A.; Fiscus, S.; Giaquinto, C.; Gibbs, D.; Harper, L.; Harrison, L.; Hughes, H. D.; McKinney, R.; Melvin, A.; Mofenson, L.; Saidi, Y.; Smith, M. E.; Tudor-Williams, G.; Walker, A. S.; Mussi-Pinhata, Marisa Márcia
Fonte: The Lancet Infectious Diseases. Unidade: FMRP
Assunto: CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BABIKER, A. et al. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. The Lancet Infectious Diseases, v. 11, n. 4, p. 273-283, 2011Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(10)70313-3. Acesso em: 03 nov. 2025.
APA
Babiker, A., Castro nee Green, H., Compagnucci, A., Fiscus, S., Giaquinto, C., Gibbs, D., et al. (2011). First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. The Lancet Infectious Diseases, 11( 4), 273-283. doi:10.1016/S1473-3099(10)70313-3
NLM
Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibbs D, Harper L, Harrison L, Hughes HD, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS, Mussi-Pinhata MM. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial [Internet]. The Lancet Infectious Diseases. 2011 ; 11( 4): 273-283.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(10)70313-3
Vancouver
Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibbs D, Harper L, Harrison L, Hughes HD, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS, Mussi-Pinhata MM. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial [Internet]. The Lancet Infectious Diseases. 2011 ; 11( 4): 273-283.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S1473-3099(10)70313-3

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada